#news #biotech Biotech vet Gilman is back, heading up next-gen CAR-T startup Obsidian

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Biotech vet Gilman is back, heading up next-gen CAR-T startup Obsidian .Michael Gilman went into retirement when Bristol-Myers Squibb bought out his Padlock Therapeutics venture last year, but has made a comeback at the helm of a new company promising to transform cell and gene therapies.

from FierceBiotech: Biotech http://ift.tt/2AzVb8l